Sherbrooke Park Advisers’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,553
Closed -$185K 1163
2024
Q3
$185K Buy
+11,553
New +$185K 0.04% 770